Skip to main content
. 2014 Oct 31;9(10):e111816. doi: 10.1371/journal.pone.0111816

Table 3. On-aspirin platelet aggregation according to genotype in 985 patients with stable coronary artery disease.

Platelet aggregation P-values
(multivariable-adjusted)
Gene Polymorphism Genotype MEA (AU × min) MEA (AU × min) VerifyNow Aspirin MEA MEA VerifyNow
(%) AA 1.0 mmol/L Collagen 1.0 µg/mL (Aspirin Reaction units) AA Collagen
ITGB3 rs5918 TT (68.5) 145 (137–154) 237 (226–249) 433 (430–436)
TC (28.5) 147 (135–160) 250 (232–270) 434 (430–438) 0.98 0.43 0.71
CC (3.0) 158 (127–197) 244 (200–299) 425 (410–439)
PTGS1 rs10306114 AA (87.0) 147 (140–154) 240 (229–250) 433 (430–435)
AG (12.5) 140 (120–164) 250 (223–282) 437 (430–444) 0.12 0.55 0.45
GG (0.5) 218 (−) 249 (−) 465 (−)
PTGS1 rs1236913 CC (86.0) 145 (138–153) 243 (233–254) 433 (431–436)
CT (13.0) 150 (132–169) 232 (208–259) 432 (426–439) 0.43 0.14 0.68
TT (1.0) 144 (94–220) 190 (115–312) 417 (404–431)
TBXA2R rs4523 GG (44.5) 147 (137–158) 238 (224–254) 432 (428–435)
GA (44.5) 142 (133–152) 238 (224–253) 434 (431–438) 0.78 0.71 0.82
AA (11.0) 160 (137–185) 266 (236–301) 434 (424–444)
TBXA2R rs1131882 GG (74.5) 145 (137–154) 238 (227–250) 431 (429–434)
GA (23.5) 146 (132–160) 244 (224–266) 439 (433–445) 0.83 0.86 0.65
AA (2.0) 208 (166–260) 335 (249–451) 430 (402–460)
P2RY1 rs1065776 CC (92.5) 147 (140–154) 241 (231–252) 433 (431–436)
CT (7.0) 137 (112–167) 242 (207–282) 435 (427–443) 0.68 0.93 0.87
TT (0.5) 133 (−) 181 (−) 402 (−)
P2RY1 rs701265 AA (75.0) 146 (138–154) 242 (231–254) 433 (430–436)
AG (23) 146 (132–160) 238 (219–259) 433 (429–438) 0.17 0.31 0.22
GG (2) 154 (118–201) 239 (188–304) 446 (429–465)
P2RY12 rs6809699 CC (72.0) 143 (135–151) 236 (225–248) 432 (429–434)
CA (26.5) 154 (141–169) 260 (240–281) 437 (432–442) 0.50 0.37 0.18
AA (1.5) 162 (123–214) 195 (146–262) 433 (419–447)
P2RY12 rs10935838 GG (71.5) 142 (134–151) 235 (224–247) 431 (429–434)
GA (27.0) 155 (143–169) 261 (242–281) 438 (433–442) 0.33 0.30 0.11
AA (1.5) 162 (123–214) 195 (146–262) 433 (419–447)
GP1BA rs6065 CC (87.5) 147 (140–155) 239 (229–250) 433 (430–435)
CT (12.0) 144 (128–161) 257 (231–285) 435 (427–443) 0.24 0.90 0.98
TT (0.5) 72 (27–192) 207 (123–349) 427 (407–449)
GP6 rs1613662 AA (69.5) 148 (140–157) 238 (226–250) 433 (430–436)
AG (27.5) 143 (131–157) 251 (232–271) 433 (428–438) 0.72 0.08 0.62
GG (3.0) 112 (76–166) 236 (182–306) 431 (418–444)
PLA2G7 rs1051931 GG (62.5) 146 (138–155) 244 (232–257) 432 (429–435)
GA (33.5) 145 (133–157) 232 (216–250) 433 (429–438) 0.73 0.10 0.13
AA (4.0) 154 (123–192) 264 (221–315) 441 (425–457)
F13A1 rs5985 CC (55.5) 146 (137–155) 234 (221–247) 432 (429–435)
CA (37.0) 146 (135–157) 253 (237–270) 435 (431–439) 0.72 0.19 0.66
AA (7.5) 150 (128–177) 237 (207–271) 434 (426–442)
PEAR1 rs12041331 GG (84.0) 150 (143–158) 249 (239–260) 434 (431–436)
GA (15.5) 126 (111–143) 203 (181–229) 431 (424–437) <0.0001 <0.0001 0.04
AA (0.5) 46 (10–203) 97 (11–859) 407 (363–456)
PEAR1 rs2768759 CC (55.0) 147 (138–157) 246 (232–260) 433 (430–436)
CA (37.5) 146 (136–157) 239 (225–254) 434 (430–438) 0.39 0.30 0.84
AA (7.5) 136 (112–165) 220 (183–265) 431 (422–441)

Values are geometric mean (95% confidence interval) or counts (%). Platelet aggregation data were logarithm transformed for analysis and back-transformed for presentation. All analyses are adjusted for the following baseline variables and cardiovascular risk factors: Age, sex, smoking, body mass index, previous myocardial infarction, diabetes, proton pump inhibitor use, and platelet count. P-values refer to differences in platelet aggregation across genotypes. Patients homozygous for the variant allele were pooled with heterozygotes for regression analysis. AA: arachidonic acid, AU: aggregation units, MEA: multiple electrode aggregometry (Multiplate Analyzer).